Booyeon Julia Han

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. David C. Linehan · 4 shared papers, 2018–2022 · strength 0.41
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
2. Bradley N. Mills · 3 shared papers, 2020–2022 · strength 0.34
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
3. Joseph D. Murphy · 3 shared papers, 2020–2022 · strength 0.34
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
4. Scott A. Gerber · 3 shared papers, 2020–2022 · strength 0.34
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
5. Jian Ye · 2 shared papers, 2020–2022 · strength 0.24
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
6. Tara G Vrooman · 1 shared paper, 2022 · strength 0.14
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
7. Jian Ye · 1 shared paper, 2020 · strength 0.11
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
8. William G. Hawkins · 1 shared paper, 2018 · strength 0.07
   • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
9. Peter S. Goedegebuure · 1 shared paper, 2018 · strength 0.07
   • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
10. Timothy M. Nywening · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
11. Dominic E. Sanford · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
12. Roheena Z. Panni · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
13. Ryan C Fields · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
14. William E. Gillanders · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗
15. David G DeNardo · 1 shared paper, 2018 · strength 0.07
    • Paper Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves che… DOI 10.1136/gutjnl-2017-313738↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.